The cytoprotective role of omentin against oxidative stress-induced PC12 apoptosis
Source abstract
Abstract
Oxidative stress has been proven to play a critical role in the pathogenesis of neuronal injury. As a novel adipocytokine, omentin is produced by visceral adipose with insulin sensitizing effects and has been revealed to possess anti-inflammatory effects. However, the possible effect of omentin on oxidative stress remains unknown. The present study aimed to detect the potential protective effect of omentin against hydrogen peroxide (H2O2)-induced cytotoxicity of PC12 cells. The results showed that no cytotoxic effect was shown in PC12 cells co-cultured with omentin alone at a concentration of 50–1000 ng/mL. The CCK8 and TUNEL assays suggested that omentin could remarkably attenuate apoptosis induced by 100 μM H2O2. The PCR and western blotting showed that the expression levels of Bax was significantly inhibited by omentin via the upregulation of miR-128-3p at its 3′-UTR. Taken together, these results indicated that omentin protects PC12 cells against H2O2-induced apoptosis, and further studies need to be conducted before utilization in the clinic for the treatment of neurodegenerative diseases.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nuclear Receptors and Signaling · Adipose Tissue and Metabolism · Autophagy in Disease and Therapy
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Medical Research Center, Xi’an No.3 Hospital, The Affiliated Hospital of Northwest University, Xi’an, China
Xi’an Key Laboratory of Cardiovascular and Cerebrovascular Diseases, The College of Life Sciences, Northwest University, Xi’an, China
Medical Research and Experimental Center, School of Medicine, Yan’an University, Yan'an, Shaanxi, China
Funding
the National Natural Science Foundation of China · Science and Technology Project of Xi’an, Shaanxi Province, China · Key Research and Development Program of Shaanxi
References (43)
Show source-provided references
1. 10.1002/ana.41044071210.1002/ana.410440712 ↗
2. 10.1038/cddis.2017.28610.1038/cddis.2017.286 ↗
3. 10.1007/s40263-014-0205-z10.1007/s40263-014-0205-z ↗
4. 10.1007/s12035-015-9337-510.1007/s12035-015-9337-5 ↗
5. 10.1002/ana.41032061610.1002/ana.410320616 ↗
6. 10.1016/S0028-3908(01)00019-310.1016/S0028-3908(01)00019-3 ↗
7. 10.1016/j.taap.2009.11.02810.1016/j.taap.2009.11.028 ↗
8. 10.1038/sj.cdd.440142010.1038/sj.cdd.4401420 ↗
9. 10.3233/JAD-13273810.3233/JAD-132738 ↗
10. 10.1096/fj.05-5359fje10.1096/fj.05-5359fje ↗
11. 10.1080/14786419.2016.124419310.1080/14786419.2016.1244193 ↗
12. 10.1007/s11011-019-0382-z10.1007/s11011-019-0382-z ↗
13. 10.1016/j.redox.2016.12.03510.1016/j.redox.2016.12.035 ↗
14. 10.1371/journal.pone.009676710.1371/journal.pone.0096767 ↗
15. 10.1186/s12894-017-0206-610.1186/s12894-017-0206-6 ↗
16. 10.1016/j.biopha.2019.10896610.1016/j.biopha.2019.108966 ↗
17. 10.1016/j.phrs.2019.10427610.1016/j.phrs.2019.104276 ↗
18. 10.1016/j.jneuroim.2008.06.01910.1016/j.jneuroim.2008.06.019 ↗
19. 10.1371/journal.pcbi.100351710.1371/journal.pcbi.1003517 ↗
20. 10.1242/dmm.02861310.1242/dmm.028613 ↗
21. 10.15252/emmm.20191194210.15252/emmm.201911942 ↗
22. 10.2337/db06-150610.2337/db06-1506 ↗
23. 10.1016/j.diabres.2011.02.03010.1016/j.diabres.2011.02.030 ↗
24. 10.1016/j.bbrc.2010.02.05310.1016/j.bbrc.2010.02.053 ↗
25. 10.1016/j.bbrc.2011.04.03910.1016/j.bbrc.2011.04.039 ↗
26. 10.1016/j.jacc.2014.03.03210.1016/j.jacc.2014.03.032 ↗
27. 10.5582/ddt.2014.0103310.5582/ddt.2014.01033 ↗
28. 10.1073/pnas.73.7.242410.1073/pnas.73.7.2424 ↗
29. Offen D, Panet H, Melamed E. Catechol-O-methyltransferase reduced levodopa toxicity in PC12 cells: implications for treatment of Parkinson's disease. Ann Neurol. 1999;46(3):459–459.
30. 10.1093/rb/rbw03210.1093/rb/rbw032 ↗
31. 10.1126/science.111212510.1126/science.1112125 ↗
32. 10.1006/exnr.2000.748910.1006/exnr.2000.7489 ↗
33. 10.1016/S0968-0004(96)20008-810.1016/S0968-0004(96)20008-8 ↗
34. 10.1038/nrn143410.1038/nrn1434 ↗
35. 10.1111/j.1471-4159.1992.tb10990.x10.1111/j.1471-4159.1992.tb10990.x ↗
36. 10.1186/1743-7075-7-2710.1186/1743-7075-7-27 ↗
37. 10.1038/aps.2011.2610.1038/aps.2011.26 ↗
38. 10.1016/j.ejphar.2012.04.03310.1016/j.ejphar.2012.04.033 ↗
39. 10.18632/aging.10263610.18632/aging.102636 ↗
40. 10.1039/c9mt00216b10.1039/c9mt00216b ↗
41. 10.1111/ane.1328810.1111/ane.13288 ↗
42. 10.1177/175342592092844910.1177/1753425920928449 ↗
43. 10.1007/s12031-016-0871-z10.1007/s12031-016-0871-z ↗